NYSE ARCA | ETF
Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries.
While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 3.76% |
| MDT | Medtronic PLC | Healthcare | Medical Devices | 3.53% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 3.50% |
| LONN | Lonza Group AG | Healthcare | Diagnostics & Research | 3.12% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 3.12% |
| UCB | UCB SA | Healthcare | Biotechnology | 2.77% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 2.65% |
| PODD | Insulet Corporation | Healthcare | Medical Devices | 2.58% |
| MTD | Mettler-Toledo International Inc | Healthcare | Diagnostics & Research | 2.53% |
| XTSLA | BlackRock Cash Funds Treasury SL Agency | 2.50% | ||
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 2.34% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 2.20% |
| COO | The Cooper Companies Inc. | Healthcare | Medical Instruments & Supplies | 2.10% |
| NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 2.04% |
| LH | Laboratory Corporation of America Holdings | Healthcare | Diagnostics & Research | 2.03% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 1.96% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 1.96% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 1.93% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 1.89% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 1.89% |